Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
Nassif, Michael E, Windsor, Sheryl L, Tang, Fengming, Khariton, Yevgeniy, Husain, Mansoor, Inzucchi, Silvio E, Mc-Guire, Darren K, Pitt, Bertram, Scirica, Benjamin M, Austin, Bethany, Drazner, Mark H, Fong, Michael W, Givertz, Michael M, Gordon, Robert A, Jermyn, Rita, Katz, Stuart D, Lamba, Sumant, Lanfear, David E, LaRue, Shane J, Lindenfeld, JoAnn, Malone, Michael, Margulies, Kenneth, Mentz, Robert J, Mutharasan, R Kannan, Pursley, Michael, Umpierrez, Guillermo, Kosiborod, Mikhail, Malik, Ali O, Wenger, Nannette, Ogunniyi, Modele, Vellanki, Priyathama, Murphy, Brenda, Newman, Jonathan, Hartupee, Justin, Gupta, Charu, Goldsmith, Marcela, Baweja, Paramdeep, Montero, Manuel, Gottlieb, Stephen S, Costanzo, Maria Rosa, Hoang, Thanh, Warnock, Alicia, Allen, Larry, Tang, Wilson, Chen, Horng H, Cox, John M
Published in Circulation (New York, N.Y.) (29.10.2019)
Published in Circulation (New York, N.Y.) (29.10.2019)
Get full text
Journal Article
Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Artery Disease, Diabetes, and Chronic Kidney Disease
Shepherd, James, Kastelein, John J.P., Bittner, Vera A., Carmena, Rafael, Deedwania, Prakash C., Breazna, Andrei, Dobson, Stephen, Wilson, Daniel J., Zuckerman, Andrea L., Wenger, Nanette K.
Published in Mayo Clinic proceedings (01.08.2008)
Published in Mayo Clinic proceedings (01.08.2008)
Get full text
Journal Article
AHA statement: Exercise training recommended in patients with type 2 diabetes
Get full text
Trade Publication Article